Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)-Reference-Cited by-同舟云学术

Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)

Published:2012-12-24 Issue:4 Volume:160 Page:538-546
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bussel James B.¹,Saleh Mansoor N.²,Vasey Sandra Y.³,Mayer Bhabita⁴,Arning Michael³,Stone Nicole L.³

Affiliation:

1. Weill Medical College of Cornell University; New York; NY; USA

2. Georgia Cancer Specialists; Atlanta; GA; USA

3. GlaxoSmithKline; Collegeville; PA; USA

4. GlaxoSmithKline; Stockley Park; Middlesex,; UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12169/fullpdf

Reference26 articles.

1. Final results of ENABLE 1, a phase 3, multicenter study of eltrombopag as an adjunct for antiviral treatment of hepatitis C virus-related chronic liver disease associated with thrombocytopenia;Afdhal;Hepatology,2011

2. The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4;AREDS;American Journal of Ophthalmology,2001

3. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy;British Committee for Standardization in Haematology;British Journal of Haematology,2003

4. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP;Bussel;New England Journal of Medicine,2006

5. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura;Bussel;New England Journal of Medicine,2007

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada;Clinical and Investigative Medicine;2024-03-01

2. Guidelines for the diagnosis and management of idiopathic thrombocytopenic purpura;Russian journal of hematology and transfusiology;2023-12-28

3. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently;Frontiers in Cardiovascular Medicine;2023-12-14

4. Long‐term eltrombopag in children with chronic immune thrombocytopenia: A single‐centre extended real‐life observational study in China;British Journal of Haematology;2023-12-12

5. Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis;Thrombosis Journal;2023-06-23